Silo Pharma Inc/$SILO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Silo Pharma Inc
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Ticker
$SILO
Sector
Primary listing
Employees
3
Headquarters
Website
Silo Pharma Inc Metrics
BasicAdvanced
$7.2m
-
-$0.50
0.59
-
Price and volume
Market cap
$7.2m
Beta
0.59
52-week high
$1.13
52-week low
$0.22
Average daily volume
8.2m
Financial strength
Current ratio
11.363
Quick ratio
10.554
Interest coverage (TTM)
-114.76%
Profitability
EBITDA (TTM)
-4.269
Gross margin (TTM)
38.57%
Net profit margin (TTM)
-5,863.50%
Operating margin (TTM)
-5,937.17%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-35.63%
Return on equity (TTM)
-74.56%
Valuation
Price to revenue (TTM)
51.401
Price to book
0.93
Price to tangible book (TTM)
0.97
Price to free cash flow (TTM)
-0.795
Free cash flow yield (TTM)
-125.79%
Free cash flow per share (TTM)
-0.556
Growth
Earnings per share change (TTM)
-57.74%
10-year revenue growth (CAGR)
4.34%
3-year earnings per share growth (CAGR)
-33.45%
10-year earnings per share growth (CAGR)
2.22%
Silo Pharma Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Silo Pharma Inc stock?
Silo Pharma Inc (SILO) has a market cap of $7.2M as of May 01, 2026.
What is the P/E ratio for Silo Pharma Inc stock?
The price to earnings (P/E) ratio for Silo Pharma Inc (SILO) stock is 0 as of May 01, 2026.
Does Silo Pharma Inc stock pay dividends?
No, Silo Pharma Inc (SILO) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Silo Pharma Inc dividend payment date?
Silo Pharma Inc (SILO) stock does not pay dividends to its shareholders.
What is the beta indicator for Silo Pharma Inc?
Silo Pharma Inc (SILO) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.